Prevent Pain and Stress Related Sickleave. (PS)

September 20, 2022 updated by: Örebro University, Sweden
Problems with stress and pain are common reasons for long-term sick-leave, and need preventive interventions. This RCT builds on a successful previous project (see reference section), where a program involving the work place, the individual and occupational health care resulted in decreased sick-leave and healthcare visits and a higher quality of life as compared to TAU for individuals with musculoskeletal pain. This study will replicate and evaluate the mechanisms behind the involvement from the work place. According to the transdiagnostic model, problems with stress and pain are maintained by similar processes. Consequently, the study will be extended to include both problems, and it will be explored how a refined version of the program affects sick leave and work ability in the employees.

Study Overview

Detailed Description

Compared to the earlier study, this RCT will include:

  1. A focused program targeting supervisors and employees
  2. An active control group
  3. An evaluation of the effects on both supervisor and employee
  4. Knowledge on the mechanisms involved
  5. Replication and extension of earlier findings

The project will produce knowledge about:

A procedure for identifying individuals at risk for sick-leave. The effects of a program targeting both workplace and individual to prevent problems with stress and pain.

The role of the supervisor in preventing sick-leave. Mechanisms linked to decreased levels of sick-leave.

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Örebro, Sweden, 70182
        • Center for Health and Medical Psychology (CHAMP) Örebro University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • participating employee has self rated symptoms of stress and/or pain and supervisor also partakes in intervention
  • employed at a workplace within Regionhälsans (occupational health care center) uptake area

Exclusion Criteria:

  • pain and/or stress symptoms due to medical conditions
  • severe psychiatric conditions
  • full time sick leave

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: communication and problem solving
Three smal group sessions (separate for employees (length 2 hours each) and for supervisors (length 2,5 hours each)) focused on training communication and problem solving skills.
a program for supervisors and employees including skills training, validating communication, problem solving
Active Comparator: psychoeducation
Two, 1 hour, lectures, one on the topic of pain and one on the topic of stress (for employees and supervisors combined).
lecture/course for supervisors and employees on risk factors and actions for people experiencing stress and/or pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sick leave
Time Frame: 14 months
days on sick leave based on register data
14 months
sick leave
Time Frame: 8 months
days on sick leave based on self report
8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
stress symptoms
Time Frame: baseline, 2 months, 8 months
change in perceived stress scale-10, assessed in employees and supervisors
baseline, 2 months, 8 months
work ability
Time Frame: 2 months, 8 months
work ability index, assessed in employees and supervisors
2 months, 8 months
exhaustion symptoms
Time Frame: baseline, 2 months, 8 months
change in Karolinska Exhaustion Disorder Scale, assessed in employees and supervisors
baseline, 2 months, 8 months
pain problems
Time Frame: baseline, 2 months, 8 months
change in Örebro Musculoskeletal Pain Screening Questionaire, assessed in employees
baseline, 2 months, 8 months
work related factors
Time Frame: 2 months, 8 months
QPS nordic, assessed in employees and supervisors
2 months, 8 months
work limitations
Time Frame: 2 months, 8 months
Work Limitations Questionnaire, assessed in employees
2 months, 8 months
symptom catastrophizing
Time Frame: baseline, 2 months, 8 months
change in Symptom Catastrophizing Scale, assessed in employees
baseline, 2 months, 8 months
problem framing
Time Frame: baseline, 2 months, 8 months
change in Pain/stress Solutions questionnaire (PaSol), assessed in employees
baseline, 2 months, 8 months
communication
Time Frame: baseline, 2 months, 8 months
change in Validation Invalidation Response Scale, assessed in employees
baseline, 2 months, 8 months
life satisfaction
Time Frame: 2 months, 8 months
Brunnsviken Brief Quality of Life scale, assessed in employees and supervisors
2 months, 8 months
health
Time Frame: 2 months, 8 months
Visual Analogue Scale (0-100, higher values better health), assessed in employees and supervisors
2 months, 8 months
communication behavior
Time Frame: baseline, 2 months
change in Validating and Invalidating Behavior Coding Scale (VIBCS, two 0-7 scales, higher scores indicate higher levels of validating and invalidating communication)
baseline, 2 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
intervention credibility
Time Frame: baseline
participant perception of intervention credibility, one item taken from the Credibility and expectancy questionnaire
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ida flink, PhD, Örebro University, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

September 1, 2022

Study Completion (Actual)

September 1, 2022

Study Registration Dates

First Submitted

May 29, 2019

First Submitted That Met QC Criteria

June 19, 2019

First Posted (Actual)

June 20, 2019

Study Record Updates

Last Update Posted (Actual)

September 21, 2022

Last Update Submitted That Met QC Criteria

September 20, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MOT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on communication and problem solving

3
Subscribe